Beijing Sun-Novo Pharmaceutical Research Co Ltd
SSE:688621
Beijing Sun-Novo Pharmaceutical Research Co Ltd
SSE:688621
Price:
66.65
CNY
-1.77%
Market Closed
Market Cap:
¥7.5B
Cash Flow Statement
Cash Flow Statement
Beijing Sun-Novo Pharmaceutical Research Co Ltd
Beijing Sun-Novo Pharmaceutical Research Co Ltd
Currency: CNY
| Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | Jun-2024 | Sep-2024 | Dec-2024 | Mar-2025 | Jun-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | ||||||||||||||||||||
| Cash Taxes Paid |
(18)
|
(19)
|
(14)
|
(13)
|
(12)
|
(14)
|
(23)
|
(26)
|
(33)
|
(33)
|
(40)
|
(40)
|
(41)
|
(41)
|
(56)
|
(55)
|
(65)
|
(70)
|
(50)
|
|
| Change in Working Capital |
(117)
|
(128)
|
(139)
|
(156)
|
(162)
|
(185)
|
(192)
|
(218)
|
(203)
|
(229)
|
(250)
|
(267)
|
(264)
|
(277)
|
(298)
|
(268)
|
(360)
|
(353)
|
(336)
|
|
| Cash from Operating Activities |
63
N/A
|
51
-20%
|
65
+28%
|
61
-6%
|
88
+44%
|
86
-3%
|
84
-2%
|
51
-40%
|
104
+105%
|
18
-83%
|
24
+37%
|
123
+414%
|
93
-24%
|
182
+96%
|
70
-62%
|
174
+149%
|
32
-82%
|
36
+13%
|
181
+400%
|
|
| Investing Cash Flow | ||||||||||||||||||||
| Capital Expenditures |
(27)
|
(27)
|
(27)
|
(38)
|
(85)
|
(115)
|
(139)
|
(142)
|
(104)
|
(101)
|
(79)
|
(78)
|
(73)
|
(60)
|
(69)
|
(47)
|
(30)
|
(17)
|
(4)
|
|
| Other Items |
(9)
|
(45)
|
(23)
|
(288)
|
(191)
|
(46)
|
(17)
|
234
|
92
|
(36)
|
(82)
|
(37)
|
(16)
|
(98)
|
(88)
|
(129)
|
(12)
|
53
|
33
|
|
| Cash from Investing Activities |
(36)
N/A
|
(72)
-101%
|
(50)
+30%
|
(326)
-548%
|
(276)
+15%
|
(161)
+42%
|
(156)
+3%
|
92
N/A
|
(12)
N/A
|
(136)
-1 083%
|
(162)
-19%
|
(115)
+29%
|
(89)
+23%
|
(158)
-78%
|
(157)
+0%
|
(177)
-12%
|
(43)
+76%
|
37
N/A
|
29
-21%
|
|
| Financing Cash Flow | ||||||||||||||||||||
| Net Issuance of Debt |
12
|
(2)
|
3
|
20
|
115
|
142
|
196
|
187
|
63
|
75
|
75
|
94
|
182
|
293
|
120
|
125
|
12
|
28
|
123
|
|
| Cash Paid for Dividends |
0
|
0
|
(1)
|
(2)
|
(1)
|
(3)
|
(25)
|
(26)
|
(27)
|
(27)
|
(55)
|
(55)
|
(56)
|
(57)
|
(11)
|
(31)
|
(38)
|
(37)
|
(55)
|
|
| Other |
(6)
|
(6)
|
458
|
457
|
455
|
447
|
(18)
|
(16)
|
(10)
|
(9)
|
(11)
|
(6)
|
(49)
|
(43)
|
(44)
|
(47)
|
(102)
|
(205)
|
(205)
|
|
| Cash from Financing Activities |
6
N/A
|
(8)
N/A
|
460
N/A
|
475
+3%
|
569
+20%
|
586
+3%
|
153
-74%
|
146
-5%
|
26
-82%
|
39
+49%
|
9
-77%
|
33
+262%
|
78
+139%
|
193
+148%
|
65
-66%
|
48
-27%
|
(128)
N/A
|
(215)
-68%
|
(137)
+36%
|
|
| Change in Cash | ||||||||||||||||||||
| Net Change in Cash |
33
N/A
|
(29)
N/A
|
474
N/A
|
210
-56%
|
381
+81%
|
511
+34%
|
81
-84%
|
288
+256%
|
119
-59%
|
(79)
N/A
|
(129)
-62%
|
40
N/A
|
82
+103%
|
217
+165%
|
(22)
N/A
|
45
N/A
|
(138)
N/A
|
(142)
-2%
|
73
N/A
|
|
| Free Cash Flow | ||||||||||||||||||||
| Free Cash Flow |
36
N/A
|
24
-34%
|
38
+59%
|
23
-38%
|
3
-86%
|
(30)
N/A
|
(55)
-86%
|
(91)
-67%
|
0
N/A
|
(83)
N/A
|
(55)
+33%
|
45
N/A
|
20
-55%
|
122
+514%
|
1
-99%
|
127
+18 869%
|
2
-99%
|
20
+1 178%
|
177
+804%
|
|
Switch to:
Switch to:
See Also
Discover More
